TruScreen Group Limited (NZE: TRU)

Market Cap	13.26M
Revenue (ttm)	2.68M
Net Income (ttm)	-1.83M
Shares Out	552.59M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	61,448
Open	0.0230
Previous Close	0.0230
Day's Range	0.0230 - 0.0240
52-Week Range	0.0150 - 0.0293
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 27, 2025

About TruScreen Group

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally. The company offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. T...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Country: New Zealand
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: TRU

Financial Performance

In 2023, TruScreen Group's revenue was 2.60 million, an increase of 25.18% compared to the previous year's 2.08 million. Losses were -2.05 million, -14.63% less than in 2022.